Avista Pharma Overview
- Founded
- 2015

- Status
- Acquired/Merged
- Employees
- 330

- Latest Deal Type
- M&A
- Financing Rounds
- 2
- Investments
- 3
Avista Pharma General Information
Description
Provider of contract development, manufacturing, and testing services of newly created medicinal drugs. The company offers a broad suite of scientifically differentiated services ranging from early-stage discovery, API and Drug Product development and cGMP manufacturing to stand-alone analytical and microbiology testing support of medicines.
Contact Information
- Durham, NC
- United States
Avista Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Avista Pharma‘s full profile, request access.
Request a free trialAvista Pharma Comparisons
Industry
00000000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAvista Pharma Competitors (26)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
MedPharm | Private Equity-Backed | Guildford, United Kingdom | 000 | 000000000 | ||
000000 | Formerly Angel backed | San Diego, CA | 00 | 00.00 | 000000&0 | 00.00 |
0000000 | Private Equity-Backed | Ann Arbor, MI | 00000 | 0000000 0000 | ||
000000 | Formerly VC-backed | San Diego, CA | 00 | 000000&0 | ||
00000000 | Formerly PE-Backed | Morristown, NJ | 0000 | 000000&0 |
Avista Pharma Patents
Avista Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210253579-A1 | Polymorphic compounds and uses thereof | Pending | 26-Nov-2019 | 0000000000 | |
US-20200270257-A1 | Chemical compounds | Pending | 30-Jan-2019 | 0000000000 | |
CA-3128024-A1 | Chemical compounds | Pending | 30-Jan-2019 | 0000000000 | |
US-20200239481-A1 | Synthetic process and novel intermediates | Pending | 30-Jan-2019 | 0000000000 | |
CA-3128346-A1 | Synthetic process and novel intermediates | Pending | 30-Jan-2019 | C07D487/04 |
Avista Pharma Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Eric Evans | Chief Financial Officer | ||
Cathy Butler | Chief Information Officer | ||
Ken Domagalski | Chief Operating Officer of CMC Operations |
Avista Pharma Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
00000 000000 | Ampersand Capital Partners | Board Member | 000 0000 |
0000 000000 00.0 | Avista Pharma | Board Member | 000 0000 |
000000 000000000 | Ampersand Capital Partners | Board Member | 000 0000 |
Avista Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAvista Pharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Avista Pharma‘s full profile, request access.
Request a free trialAvista Pharma Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000 00 | 23-Jan-2018 | 0000000000 | Biotechnology | 0000000 0 | |
000000000 000 | 07-Aug-2015 | 0000000000 | Laboratory Services (Healthcare) | ||
Scynexis (Contract Services Business) | 23-Jul-2015 | Merger/Acquisition | Pharmaceuticals | 0000000 0 |
Avista Pharma Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
00000 0000 0000000 | Biotechnology | Penicuik, United Kingdom | 0000 |
Avista Pharma Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000 000 0000 | 07-Aug-2015 | 000000000000000000 | Completed |
|